KARA CARDINAL: Open Payments
NPI 1619065331 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 36 payments from 18 companies in 2025. Trend: 2023 $624 · 2024 $680 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 4 | $119 |
| Calyxo, Inc. | 5 | $102 |
| Sumitomo Pharma America, Inc. | 4 | $75 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $72 |
| Endo USA, Inc. | 3 | $60 |
| Boston Scientific Corporation | 1 | $59 |
| Olympus America Inc. | 2 | $53 |
| Ethicon US, LLC | 1 | $48 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| ABBVIE INC. | 2 | $36 |
Products named: CVAC ASPIRATION SYSTEM, PYLARIFY, AVEED, ORGOVYX, General - Kidney Stone Disease, iTIND System, ETHICON, BOTOX.
Industry payments across MO — which companies pay providers there.
